Www.alcoholandhealth.org1 Journal Club Alcohol and Health: Current Evidence July–August 2004.

Slides:



Advertisements
Similar presentations
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2014.
Advertisements

Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2014.
Journal Club Alcohol and Health: Current Evidence September–October 2006.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2013.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July-August 2007.
Journal Club Alcohol and Health: Current Evidence March-April 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2009.
Journal Club Alcohol and Health: Current Evidence November–December 2004.
Journal Club Alcohol and Health: Current Evidence May–June 2005.
Journal Club Alcohol and Health: Current Evidence March-April 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence April 2008.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2010.
Journal Club Alcohol and Health: Current Evidence July-August 2006.
Journal Club Alcohol and Health: Current Evidence July–August 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2009.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2011.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2011.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September-October 2007.
Journal Club Alcohol and Health: Current Evidence November-December 2005.
Journal Club Alcohol and Health: Current Evidence March-April 2006.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2010.
Journal Club Alcohol and Health: Current Evidence January-February 2006.
Journal Club Alcohol and Health: Current Evidence November–December 2006.
Journal Club Alcohol and Health: Current Evidence May-June 2006.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
Journal Club Alcohol and Health: Current Evidence September–October 2004.
Journal Club Alcohol and Health: Current Evidence January-February 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2009.
Journal Club Alcohol and Health: Current Evidence September-October 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2014.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2015.
Journal Club Alcohol and Health: Current Evidence January–February 2007.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2009.
EVIDENCE BASED MEDICINE
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
Body Weight and Mortality: New Population Based Evidences Body Weight and Mortality: New Population Based Evidences Dongfeng Gu, MD Dongfeng Gu, MD Fu.
C-REACTIVE PROTEIN, FIBRINOGEN, AND CARDIOVASCULAR DISEASE PREDICTION By Patrick Whitledge PA-S2 South University Physician Assistant Program.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2012.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2014.
‘STROKE’ February 2011 Dr Amer Jafar ABHB/Gwent. Decreased Kidney Function  Chronic kidney disease is an important risk factor for development and progression.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2012.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2012.
Pai JK et al. N Engl J Med 2004; 351: Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2012.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2014.
To assess the prognostic value of variability in home-measured blood pressure (BP) and heart rate (HR) in a general population. Objective: Methods: BP.
Prognosis study EBM questions. Prognostic factors Characteristics of patient that may predict eventual outcome Several types: demographic (eg age) disease-specific.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2015.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2012.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December, 2015.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2013.
Kelsey Vonderheide, PA1.  Heart Failure—a large number of conditions affecting the structure and function of the heart that make it difficult for the.
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Addressing Unhealthy Alcohol Use in Older Populations in Primary Care
Alcohol, Other Drugs, and Health: Current Evidence March–April 2017
Coffee drinking and leukocyte telomere length: A meta-analysis
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
Alcohol, Other Drugs, and Health: Current Evidence March–April 2018
Alcohol, Other Drugs, and Health: Current Evidence
Alcohol, Other Drugs, and Health: Current Evidence
Alcohol, Other Drugs, and Health: Current Evidence May–June 2019
Presentation transcript:

Journal Club Alcohol and Health: Current Evidence July–August 2004

Featured Article Alcohol Consumption and Cardiovascular Disease Mortality in Hypertensive Men Malinski MK, et al. Arch Intern Med. 2004;164(6):623–628.

Study Objective To assess the relationship between moderate alcohol consumption and cardiovascular disease (CVD) mortality total mortality among men with hypertension

Study Design A prospective cohort study of physicians with current or past hypertension

Assessing Validity of an Article about Prognosis –Are the results valid? –What are the results? –How can I apply the results to patient care?

Are the Results Valid? Was the sample of patients representative? Were the patients sufficiently homogeneous with respect to prognostic risk? Was follow-up sufficiently complete? Were objective and unbiased outcome criteria used?

Was the sample of patients representative? Subjects: –all males –physicians –history of current or past treatment for hypertension –without myocardial infarction, stroke, cancer, or liver disease at baseline

Were the patients sufficiently homogeneous with respect to prognostic risk? Subjects weren’t necessarily at the same point in the course of their hypertension. –However, none had experienced hypertension complications. Potential confounders adjusted for include: –age, smoking, exercise, body mass index, history of angina, and diabetes.

Was follow-up sufficiently complete? The percent loss to follow-up is unknown. –Researchers followed subjects for an average of 5.4 years. –They appropriately used survival statistical methods to analyze data.

Were objective and unbiased outcome criteria used? Deaths were determined by review of a national death database. Trained nosologists determined mortality and cardiovascular mortality by reviewing death certificates for any deaths.

What are the Results? How likely are the outcomes over time? How precise are the estimates of likelihood?

How likely are the outcomes and how precise are the estimates? 7% of subjects died in 5 years. Monthly Consumption (n=1505) Weekly Consumption (n=5710) Daily Consumption (n=4472) P Value for Trend Total Mortality 0.86* (CI 0.67–1.10) 0.72 (CI 0.60–0.86) 0.73 (CI 0.61–0.87) <0.001 CVD Mortality 0.83 (CI 0.62–1.13) 0.61 (CI 0.49–0.77) 0.56 (CI 0.44–0.71) <0.001 *Adjusted relative risk; compared to those who rarely/never drank (n=2438)

How Can I Apply the Results to Patient Care? Were the study patients and their management similar to those in my practice? Was the follow-up sufficiently long? Can I use the results in the management of patients in my practice?

Were the study patients and their management similar to those in my practice? They are probably similar given that both moderate drinking and hypertension are common. How hypertension was managed in this large study is unknown and probably very variable. The results are not relevant to heavy drinkers.

Was the follow-up sufficiently long? Follow-up was long enough to accrue sufficient numbers of outcomes to show differences by alcohol consumption levels.

Can I use the results in the management of patients in my practice? Authors note several limitations: Self-reported, non-validated measure of alcohol intake, at one point in time –Unable to assess drinking patterns or changes –No comparison of different types of alcohol –Addressed how often but not how much

Can I use the results in the management of patients in my practice? (cont.) Self-reported blood pressure and hypertension values potentially subject to misclassification Possibly tainted reference group that may include former drinkers who stopped drinking due to comorbid conditions that raised their risk of death Lack of generalizability to populations with higher levels of consumption

Can I use the results in the management of patients in my practice? (cont.) The 2 most important issues that limit the utility of this study: It was not a randomized trial. –The results could be due to other factors (e.g., unmeasured confounders like healthy behaviors). It reported only how often, but not how much, study subjects were drinking.

Can I use the results in the management of patients in my practice? (cont.) These results—moderate drinking does not increase, and may decrease, mortality in men with hypertension—suggest that there is no imperative for these men to cut down or abstain. –In fact, abstinence may increase risk of death in men with hypertension who drink moderate amounts.

Can I use the results in the management of patients in my practice? (cont.) The results, if replicated, suggest that moderate drinking may be beneficial for men with hypertension, with respect to reducing total and cardiovascular mortality. Although unknown, results may not apply to men with comorbidity, women, or to patients with worse blood pressure control (or end organ damage).